Sheldon R - Search Results

1

Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.

Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M. Sheldon R, et al. Circulation. 2000 Apr 11;101(14):1660-4. doi: 10.1161/01.cir.101.14.1660. Circulation. 2000. PMID: 10758047 Clinical Trial.

2

Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.

Sheldon R, O'Brien BJ, Blackhouse G, Goeree R, Mitchell B, Klein G, Roberts RS, Gent M, Connolly SJ. Sheldon R, et al. Circulation. 2001 Oct 2;104(14):1622-6. doi: 10.1161/hc3901.096720. Circulation. 2001. PMID: 11581139

3

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome.

Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, Sheldon R, Talajic M, Dorian P, Newman D. Humphries KH, et al. Among authors: sheldon r. Circulation. 2001 May 15;103(19):2365-70. doi: 10.1161/01.cir.103.19.2365. Circulation. 2001. PMID: 11352885

4

Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.

Sheldon R, Rose S, Connolly S. Sheldon R, et al. Europace. 2003 Jan;5(1):71-5. doi: 10.1053/eupc.2002.0284. Europace. 2003. PMID: 12504644 Clinical Trial.

5

The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.

Connolly SJ, Sheldon R, Roberts RS, Gent M. Connolly SJ, et al. Among authors: sheldon r. J Am Coll Cardiol. 1999 Jan;33(1):16-20. doi: 10.1016/s0735-1097(98)00549-x. J Am Coll Cardiol. 1999. PMID: 9935002 Free article. Clinical Trial.

6

How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators.

Krahn AD, Klein GJ, Kerr CR, Boone J, Sheldon R, Green M, Talajic M, Wang X, Connolly S. Krahn AD, et al. Among authors: sheldon r. Arch Intern Med. 1996 Oct 28;156(19):2221-4. Arch Intern Med. 1996. PMID: 8885821

7

Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope.

Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Sheldon R, et al. Circulation. 1996 Mar 1;93(5):973-81. doi: 10.1161/01.cir.93.5.973. Circulation. 1996. PMID: 8598089

8

Antiarrhythmic activity of quinine in humans.

Sheldon R, Duff H, Koshman ML. Sheldon R, et al. Circulation. 1995 Nov 15;92(10):2944-50. doi: 10.1161/01.cir.92.10.2944. Circulation. 1995. PMID: 7586264 Clinical Trial.

9

Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation.

Kerr C, Boone J, Connolly S, Greene M, Klein G, Sheldon R, Talajic M. Kerr C, et al. Among authors: sheldon r. Eur Heart J. 1996 Jul;17 Suppl C:48-51. doi: 10.1093/eurheartj/17.suppl_c.48. Eur Heart J. 1996. PMID: 8809539 Review.

10

Origins of heart rate variability. Inducibility and prevalence of a discrete, tachycardic event.

Roach D, Malik P, Koshman ML, Sheldon R. Roach D, et al. Among authors: sheldon r. Circulation. 1999 Jun 29;99(25):3279-85. doi: 10.1161/01.cir.99.25.3279. Circulation. 1999. PMID: 10385503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

688 results

Search Page

Filters